254 related articles for article (PubMed ID: 26237436)
21. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
22. American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002.
Sverzellati N; Lynch DA; Hansell DM; Johkoh T; King TE; Travis WD
Radiographics; 2015; 35(7):1849-71. PubMed ID: 26452110
[TBL] [Abstract][Full Text] [Related]
23. Differentiating between IPF and NSIP.
Glaspole I; Goh NS
Chron Respir Dis; 2010 Aug; 7(3):187-95. PubMed ID: 20688895
[TBL] [Abstract][Full Text] [Related]
24. Predictors of survival in idiopathic interstitial pneumonia.
Carbone R; Bottino G; Paredi P; Shah P; Meyer KC
Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):695-704. PubMed ID: 20707290
[TBL] [Abstract][Full Text] [Related]
25. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
[TBL] [Abstract][Full Text] [Related]
26. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
28. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
29. Unclassifiable interstitial lung disease: A review.
Skolnik K; Ryerson CJ
Respirology; 2016 Jan; 21(1):51-6. PubMed ID: 26059704
[TBL] [Abstract][Full Text] [Related]
30. Clinico-radio-pathological characteristics of unclassifiable idiopathic interstitial pneumonias.
Nakamura Y; Sugino K; Kitani M; Hebisawa A; Tochigi N; Homma S
Respir Investig; 2018 Jan; 56(1):40-47. PubMed ID: 29325680
[TBL] [Abstract][Full Text] [Related]
31. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
Kreuter M; Ehlers-Tenenbaum S; Schaaf M; Oltmanns U; Palmowski K; Hoffmann H; Schnabel PA; Heußel CP; Puderbach M; Herth FJ; Warth A
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):266-74. PubMed ID: 25591137
[TBL] [Abstract][Full Text] [Related]
32. Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification system.
Kadoch MA; Cham MD; Beasley MB; Ward TJ; Jacobi AH; Eber CD; Padilla ML
Curr Probl Diagn Radiol; 2015; 44(1):15-25. PubMed ID: 25512168
[TBL] [Abstract][Full Text] [Related]
33. [Chinese expert consensus on multidisciplinary discussion of interstitial lung disease].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1176-1188. PubMed ID: 37989522
[TBL] [Abstract][Full Text] [Related]
34. [Idiopathic interstitial pneumonias].
Lazor R; Letovanec I; Beigelman C
Rev Prat; 2014 Sep; 64(7):933-7, 939-40. PubMed ID: 25362773
[TBL] [Abstract][Full Text] [Related]
35. Treatment strategies for idiopathic interstitial pneumonias.
Wells AU; Kokosi M; Karagiannis K
Curr Opin Pulm Med; 2014 Sep; 20(5):442-8. PubMed ID: 25032814
[TBL] [Abstract][Full Text] [Related]
36. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
[TBL] [Abstract][Full Text] [Related]
37. Challenges in IPF diagnosis, current management and future perspectives.
Wells AU; Costabel U; Poletti V; Crestani B; Egan J; Margaritopoulos G; Antoniou K
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():28-35. PubMed ID: 26237442
[TBL] [Abstract][Full Text] [Related]
38. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
39. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
40. Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.
Storme M; Semionov A; Assayag D; Lefson M; Kitty D; Dannenbaum D; Torrie J; Lejeune P; Robinson E; Ahmad Khan F
PLoS One; 2017; 12(9):e0184548. PubMed ID: 28886193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
